Clinical Trial: A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis

U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07529925) titled 'A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis' on April 08.

Brief Summary: This study is a real-world clinical study of adalimumab. The project plans to enrol 30 participants and aims to evaluate the efficacy and safety of adalimumab in Chinese children with plaque psoriasis, with the primary endpoint being the proportion of participants achieving PASI 75 (PASI score reduction >=75% from baseline) at week 16.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Severe Plaque Psoriasis in Chinese Children

Intervention: DRUG: Adalimumab Solution for Injection

Adalimumab i...